Skip to content
No picture yet

Mylan-Almotriptan 12.5 mg – DIN 02398443

Mylan-Almotriptan is Almotriptan Malate 12.5 mg (tablet), sold in Canada. It is used for migraine. It is supplied by Mylan Pharmaceuticals ULC. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Almotriptan Malate 12.5 mg

Brand
Mylan-Almotriptan
Strength
12.5 mg
Used for
Migraine
Form
Tablet
Manufacturer
Mylan Pharmaceuticals ULC
Drug class
Triptan (migraine medicine)
Sold in
Canada
DIN
02398443

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Almotriptan Malate pills and guides

What is Almotriptan Malate used for?

Almotriptan Malate is used for migraine.

Medicine type
Triptan (migraine medicine)
Official uses from the US prescribing label

Acute Treatment of Migraine Attacks

Adults

Almotriptan malate tablets are indicated for the acute treatment of migraine attacks in patients with a history of migraine with or without aura.

Adolescents Age 12 to 17 Years

Almotriptan malate tablets are indicated for the acute treatment of migraine headache pain in patients with a history of migraine attacks with or without aura usually lasting 4 hours or more (when untreated).

Important Limitations

Almotriptan malate tablets should only be used where a clear diagnosis of migraine has been established. If a patient has no response for the first migraine attack treated with almotriptan malate tablets, the diagnosis of migraine should be reconsidered before almotriptan malate tablets are administered to treat any subsequent attacks.

In adolescents age 12 to 17 years, efficacy of almotriptan malate tablets on migraine-associated symptoms (nausea, photophobia, and phonophobia) was not established. Almotriptan malate tablets are not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine.

Safety and effectiveness of almotriptan malate tablets have not been established for cluster headache which is present in an older, predominantly male population.

From the FDA-approved label on DailyMed (published Aug 28, 2020).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02398443.
  • It names Mylan-Almotriptan, Almotriptan Malate 12.5 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Mylan-Almotriptan by Mylan Pharmaceuticals ULC.

In Canada: prescription only.

Ingredients

Active: Almotriptan (Almotriptan Malate)

Other Almotriptan Malate pills